Consensus on women's health aspects of polycystic ovary syndrome (PCOS). (Q37965510)

26 August 2017

Consensus on women's health aspects of polycystic ovary syndrome (PCOS). (English)

1 reference

polycystic ovary syndrome

26 August 2017

1 reference

1 reference

1 reference

ORCID Public Data File 2021

author name string

Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group

series ordinal

1

1 reference

PubMed ID

22147920

26 August 2017

language of work or name

English

0 references

publication date

5 December 2011

1 reference

26 August 2017

1 reference

26 August 2017

27

1 reference

26 August 2017

14-24

1 reference

26 August 2017

1

1 reference

Criteria for polycystic ovarian morphology in polycystic ovary syndrome as a function of age.

26 August 2017

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDER396

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDER396

Polycystic ovary syndrome in adolescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDER396

A meta-analysis of pregnancy outcomes in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDER396

Polycystic ovary syndrome and the risk of gynaecological cancer: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDER396

Increased risk of non-insulin dependent diabetes mellitus, arterial hypertension and coronary artery disease in perimenopausal women with a history of the polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDER396

Clinical review: Insulin sensitizers for the treatment of hirsutism: a systematic review and metaanalyses of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDER396

Metformin versus oral contraceptive pill in polycystic ovary syndrome: a Cochrane review

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDER396

Development of a health-related quality-of-life questionnaire (PCOSQ) for women with polycystic ovary syndrome (PCOS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDER396

Androgen levels in adult females: changes with age, menopause, and oophorectomy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDER396

Increased risk for abnormal depression scores in women with polycystic ovary syndrome: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDER396

Polycystic ovary syndrome and oocyte developmental competence

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDER396

Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDER396

Insulin secretory defects in polycystic ovary syndrome. Relationship to insulin sensitivity and family history of non-insulin-dependent diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDER396

Obesity, rather than menstrual cycle pattern or follicle cohort size, determines hyperinsulinaemia, dyslipidaemia and hypertension in ageing women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDER396

When should an insulin sensitizing agent be used in the treatment of polycystic ovary syndrome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDER396

Polycystic ovary syndrome in Mexican-Americans: prevalence and association with the severity of insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDER396

Metformin or antiandrogen in the treatment of hirsutism in polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDER396

Polycystic ovary syndrome and mental health: A review

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDER396

Long-term follow-up of patients with polycystic ovary syndrome: reproductive outcome and ovarian reserve

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDER396

The polycystic ovary post-rotterdam: a common, age-dependent finding in ovulatory women without metabolic significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDER396

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDER396

Searching for polycystic ovary syndrome in postmenopausal women: evidence of a dose-effect association with prevalent cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDER396

A simple screening approach for assessing community prevalence and phenotype of polycystic ovary syndrome in a semi-urban population in Sri Lanka

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDER396

New approach to polycystic ovary syndrome and other forms of anovulatory infertility

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDER396

Polycystic ovaries are common in women with hyperandrogenic chronic anovulation but do not predict metabolic or reproductive phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDER396

Epidemiology and adverse cardiovascular risk profile of diagnosed polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDER396

The central issue? Visceral fat mass is a good marker of insulin resistance and metabolic disturbance in women with polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDER396

Comparison of spironolactone, flutamide, and finasteride efficacy in the treatment of hirsutism: a randomized, double blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDER396

Treatment of obesity in polycystic ovary syndrome: a position statement of the Androgen Excess and Polycystic Ovary Syndrome Society.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDER396

Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDER396

Changes in anti-Müllerian hormone serum concentrations over time suggest delayed ovarian ageing in normogonadotrophic anovulatory infertility

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDER396

Comparison of Sequential Cyproterone Acetate/Estrogen Versus Spironolactone/Oral Contraceptive in the Treatment of Hirsutism

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDER396

Mortality of women with polycystic ovary syndrome at long-term follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDER396

Epithelial ovarian cancer risk among women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDER396

Postmenopausal women with a history of irregular menses and elevated androgen measurements at high risk for worsening cardiovascular event-free survival: results from the National Institutes of Health--National Heart, Lung, and Blood Institute spons

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDER396

Long or highly irregular menstrual cycles as a marker for risk of type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDER396

Is polycystic ovary syndrome an exception for reproductive aging?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDER396

Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDER396

Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDER396

Consensus on infertility treatment related to polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDER396

Consensus on infertility treatment related to polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDER396

Predictive value of menstrual cycle pattern, body mass index, hormone levels and polycystic ovaries at age 15 years for oligo-amenorrhoea at age 18 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDER396

Metformin versus placebo from first trimester to delivery in polycystic ovary syndrome: a randomized, controlled multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDER396

Lack of association between polycystic ovary syndrome and embryonic aneuploidy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDER396

Phenotype and metabolic profile of South Asian women with polycystic ovary syndrome (PCOS): results of a large database from a specialist Endocrine Clinic.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDER396

Long-term consequences of polycystic ovary syndrome: results of a 31 year follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDER396

Oral contraceptives in polycystic ovary syndrome: risk-benefit assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDER396

Association of biochemical hyperandrogenism with type 2 diabetes and obesity in Chinese women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDER396

21 January 2018

Identifiers

DOI

10.1093/HUMREP/DER396

1 reference

26 August 2017

1 reference

PubMed ID

22147920